#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cryoglobulinaemia Myasthenia gravis Squamous cell carcinoma of the oral cavity Hereditary hypophosphataemic rickets Plasma cell myeloma Non-small cell lung cancer Immune-mediated myositis Essential thrombocythaemia Antithrombin III deficiency Prostate cancer Antiphospholipid syndrome Adrenogenital syndrome Gastrointestinal stromal tumour Chronic lymphocytic leukaemia refractory Neonatal asphyxia More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma – Basic Information Congenital generalised lipodystrophy – Trials in Disease Lymphangiosarcoma – Treatment Soft tissue sarcoma – Trials in Disease MELAS syndrome – Life with Disease Angelman’s syndrome Primary immunodeficiency syndrome – Diagnostics Fabry’s disease – Life with Disease Skin angiosarcoma – Basic Information Combined immunodeficiency – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Levofloxacin Tub-040 Propofol Emicizumab Mosaic Hbcoreag INF904 Rocatinlimab Indacaterol Acetate Baricitinib Histidine N-Tec Levodropropizine Amitriptyline Egl-001 Sxr1096 Difelikefalin Potassium Iodide Soya Oil Acetylcholine Chloride 177LU-FAP-2286 More therapies…

    Learn about Your Condition

    Vertigo Tumour thrombosis Injection site pain Incisional hernia Autoimmune hepatitis Metachromatic leukodystrophy Cardiac sarcoidosis Generalised anxiety disorder Procedural pain Metastases to peritoneum Cerebellar ataxia Hand fracture Inguinal hernia Tendon injury Eosinophilic oesophagitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Adding OSU6162 to Treatment for Patients with Depression Resistant to SSRI/SNRI Medications

    Recruiting

    2 1
    Investigated Drugs:
    • 3-(3-Methanesulfonyl-Phenyl)-1-Propyl-Piperidine Hydrochloride
    • Placebo
    Sweden

  • Study on Maintenance Treatment with Pembrolizumab and Pemetrexed for Stage IV Non-Small Cell Lung Cancer Patients After Initial Chemotherapy and Immunotherapy

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage IV
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Paclitaxel
    France

  • Study on the Safety and Effects of AP1189 for Patients with Idiopathic Membranous Nephropathy and Severe Proteinuria

    Recruiting

    2 1
    Investigated Drugs:
    • Resomelagon
    Denmark Sweden

  • Study Comparing Irinotecan, Fluorouracil, Folinic Acid, and Drug Combination for Patients with Metastatic Pancreatic Cancer

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma metastatic
    • Pancreatic carcinoma
    Investigated Drugs:
    • Fluorouracil
    • Folinic Acid
    • Gemcitabine
    France

  • Study on Dexamethasone Phosphate for Reducing Breathing Problems in Children with Upper Airway Obstruction in Intensive Care

    Recruiting

    3 1 1
    Investigated Drugs:
    • Dexamethasone Phosphate
    France

  • Study on Blinatumomab, Ponatinib, and Isatuximab for Adults Aged 18-65 with Newly Diagnosed Acute Lymphoblastic Leukemia or T-Cell Lymphoblastic Lymphoma

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Lymphocytic leukaemia
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Blinatumomab
    • Isatuximab
    • Ponatinib
    Belgium France
Previous Page
1 … 628 629 630 631 632 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!